Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Molecular Pharmaceutics|December 27, 2019
Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based PredictionAntonello Caruso, Matthias Füth, Ruben Alvarez-Sánchez, et al.Biophysical Journal|November 21, 2020
Conformational Ensembles of Antibodies Determine Their HydrophobicityFranz Waibl, Monica L Fernández-Quintero, Anna S Kamenik, et al.Mabs|August 29, 2012
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodiesChristian Klein, Claudio Sustmann, Markus Thomas, et al.Nature Communications|January 30, 2021
DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneouslyRoland Beckmann, Kristian Jensen, Sebastian Fenn, et al.Frontiers in Immunology|August 27, 2021
Germline-Dependent Antibody Paratope States and Pairing Specific VH-VL Interface DynamicsMonica L Fernández-Quintero, Katharina B Kroell, Lisa M Bacher, et al.Journal of Chemical Information and Modeling|November 7, 2023
PEP-Patch: Electrostatics in Protein-Protein Recognition, Specificity, and Antibody DevelopabilityValentin J Hoerschinger, Franz Waibl, Nancy D Pomarici, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2019
Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical ChallengesSimone Schadt, Simon Hauri, Filipe Lopes, et al.Frontiers in Immunology|July 15, 2026
The immunogenicity database collaborative: a standardized, publicly available database for clinical immunogenicity observations and insightsSudhanshu Agnihotri, Bruno Gonzalez-Nolasco, Brinda Monian, et al.Mabs|February 12, 2016
Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2Werner Scheuer, Markus Thomas, Petra Hanke, et al.Frontiers in Bioengineering and Biotechnology|November 12, 2024
Procollagen-lysine 2-oxoglutarate 5-dioxygenases are responsible for 5R-hydroxylysine modification of therapeutic T-cell bispecific monoclonal antibodies produced by Chinese hamster ovary cellsNiels Bauer, Marco Boettger, Styliani Papadaki, et al.Pageof 4